Search - tctmd.com

Displaying 21 - 40 of 153

Sort: Relevancy | Date

Presentation NY Valves 2024

PRO: TMVR Is a Good Option for Functional MR

Presenter: Chet Rihal

June 06, 2024

Presentation NY Valves 2024

Treatment Options for Functional MR: ADVANCED GDMT, M-TEER, TMVR, and Surgery – What Does the Evidence Show?

Presenter: Javed Butler

June 06, 2024

Presentation NY Valves 2024

CON: M-TEER for ALL Phenotypes – Symptomatic Improvement Is Enough

Presenter: Michael Joseph Rinaldi

June 06, 2024

Presentation NY Valves 2024

PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear

Presenter: JoAnn Lindenfeld

June 06, 2024

Presentation NY Valves 2024

The Heterogeneity of Functional MR: Phenotype Clusters and Implications for Management

Presenter: Anna Sannino

June 06, 2024

Presentation NY Valves 2024

Secondary MR and GDMT Titration Before M-TEER in the Real-world

Presenter: Donna Mancini

June 05, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Daily News

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Michael O'Riordan

March 20, 2024

News Daily News

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Michael O'Riordan

March 15, 2024

News Daily News

Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details

Michael O'Riordan

January 25, 2024

News Conference News PCR London Valves 2023

EuroSMR Score Outperforms Other Tools for M-TEER Risk Profiling

Shelley Wood

November 28, 2023

News Conference News TCT 2023

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

Yael L. Maxwell

November 02, 2023

News Conference News TCT 2023

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

Yael L. Maxwell

October 30, 2023

Presentation TCT 2023

Case-Based: Patient Selection for Mitral Transcatheter Edge-to-Edge Repair in Secondary MR – Turning Controversy Into Learning

Presenter: Federico Asch

October 24, 2023

Presentation TCT 2023

Mitral Transcatheter Edge-to-Edge Repair for Secondary MR in the Management of HFrEF: Where Does It Fit in?

Presenter: Marianna Adamo

October 24, 2023

Presentation TCT 2023

Will Advances in GDMT Reduce Need for Mitral TEER in Secondary MR?

Presenter: JoAnn Lindenfeld

October 24, 2023

Presentation TCT 2023

My 5 Key Features for Morphological Suitability of Mitral Transcatheter Edge-to-Edge Repair in Primary MR

Presenter: Sam Dawkins

October 24, 2023

Presentation TCT 2023

Mitral Transcatheter Edge-to-Edge Repair in Intermediate and Low-Risk Patients: Rationale, Evidence, and Ongoing Studies

Presenter: Gorav Ailawadi

October 24, 2023

Presentation TCT 2023

Current Evidence for M-Transcatheter Edge-to-Edge Repair in Primary MR

Presenter: Khung Keong Yeo

October 24, 2023

Advertisement

PRO: TMVR Is a Good Option for Functional MR

Treatment Options for Functional MR: ADVANCED GDMT, M-TEER, TMVR, and Surgery – What Does the Evidence Show?

CON: M-TEER for ALL Phenotypes – Symptomatic Improvement Is Enough

PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear

The Heterogeneity of Functional MR: Phenotype Clusters and Implications for Management

Secondary MR and GDMT Titration Before M-TEER in the Real-world

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Evoque and Patisiran: A Tale of Two Regulatory Journeys

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details

EuroSMR Score Outperforms Other Tools for M-TEER Risk Profiling

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

Case-Based: Patient Selection for Mitral Transcatheter Edge-to-Edge Repair in Secondary MR – Turning Controversy Into Learning

Mitral Transcatheter Edge-to-Edge Repair for Secondary MR in the Management of HFrEF: Where Does It Fit in?

Will Advances in GDMT Reduce Need for Mitral TEER in Secondary MR?

My 5 Key Features for Morphological Suitability of Mitral Transcatheter Edge-to-Edge Repair in Primary MR

Mitral Transcatheter Edge-to-Edge Repair in Intermediate and Low-Risk Patients: Rationale, Evidence, and Ongoing Studies

Current Evidence for M-Transcatheter Edge-to-Edge Repair in Primary MR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content